Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome is the indication for 7 drugs in DrugBank. It is covered by 9 curated, structured indications.

Also known as: Lennox Gastaut Syndrome · Lennox-Gastaut Syndrome (LGS) · Lennox Gastaut Syndrome (LGS)
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mental Disorders
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Cannabidiol
Clobazam
Clonazepam
Fenfluramine
Lamotrigine
Rufinamide
Topiramate

Resolves to

Vocabularies

MeSHM0590747ICD-10G40.81SNOMED CT192984003MedDRA10048816UMLSC0238111

What you can answer from here — as of November 01, 2026

7Indicated drugsWith each drug's targets and mechanism

Listed above

9Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

52Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Lennox-Gastaut Syndrome share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.